Evidence map›Paper›PMID 35330006›Full record

ArticleJournal of clinical medicine2022

Coronavirus Disease Transmission Prevented in an Endoscopy Unit with Universal Protective Measures and No Systematic Preprocedural Testing.

Lucía Guilabert, José Ramón Aparicio, Lucía Medina-Prado, Juan Carlos Rodríguez-Díaz, María Luisa Gomis, Pablo Chico-Sánchez, José Sánchez-Payá, Rodrigo Jover

Abstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lucía GuilabertGastroenterology Department, Instituto de Investigación Biomédica ISABIAL, Hospital General Universitario de Alicante, 03010 Alicante, Spain.ORCID 0000-0002-9597-6377
José Ramón AparicioGastroenterology Department, Instituto de Investigación Biomédica ISABIAL, Hospital General Universitario de Alicante, 03010 Alicante, Spain.ORCID 0000-0003-2245-4006
Lucía Medina-PradoGastroenterology Department, Instituto de Investigación Biomédica ISABIAL, Hospital General Universitario de Alicante, 03010 Alicante, Spain.
Juan Carlos Rodríguez-DíazMicrobiology Derpartment, Instituto de Investigación Biomédica ISABIAL, Hospital General Universitario de Alicante, 03010 Alicante, Spain.ORCID 0000-0001-8007-5739
María Luisa GomisGastroenterology Department, Instituto de Investigación Biomédica ISABIAL, Hospital General Universitario de Alicante, 03010 Alicante, Spain.
Pablo Chico-SánchezPreventive Healthcare Department, Instituto de Investigación Biomédica ISABIAL, Hospital General Universitario de Alicante, 03010 Alicante, Spain.ORCID 0000-0003-2809-8751
José Sánchez-PayáPreventive Healthcare Department, Instituto de Investigación Biomédica ISABIAL, Hospital General Universitario de Alicante, 03010 Alicante, Spain.
Rodrigo JoverGastroenterology Department, Instituto de Investigación Biomédica ISABIAL, Hospital General Universitario de Alicante, 03010 Alicante, Spain.

Funding

Fundación de Investigación Biomédica de la Comunidad Valenciana-Instituto de Investigación Sanitaria y Biomédica de Alicante Foundation UGP-20-265Instituto de Salud Carlos III PI20/01527
6 · The paper itself

Abstract

BACKGROUND AND

aimsEven after two years of pandemic, there are still uncertainties on how to proceed when we schedule endoscopic procedures. During the COVID-19 pandemic, some scientific societies recommended universal preprocedural testing for all patients. However, other societies recommended against and considered enough to maintain strict infection control strategies. Our aim was to evaluate this approach in order to see if it was safe for both patients and healthcare workers to proceed with the endoscopies without performing a systematic PCR on all patients.

methodsRetrospective chart review of all patients undergoing endoscopy without preprocedural COVID testing at our center from March 2020 to May 2021. PCR tests performed in the patients receiving an endoscopic procedure were analyzed, and patients who tested positive between 14 days before and after the endoscopic procedure were selected. The registry of the endoscopy unit members participating in these procedures was also analyzed.

resultsA total of 10,132 procedures were performed in the unit with 26 patients infected with SARS-CoV-2. Nineteen of these procedures were performed in patients with unknown SARS-CoV-2 carrier status. In 23 (88.5%) cases, transmission occurred through social or familial contact, and in 3 (11.5%), transmission occurred in the hospital. Four health care workers became infected during this period and none of them were related to the endoscopic procedures performed in patients with COVID-19.

conclusionsSARS-CoV-2 positive testing in asymptomatic ambulatory patients is rare and the adequate use of individual protective measures emerges as the main way to control the spread of COVID-19 infection in endoscopy centers.

Indexed as

coronavirusCOVID-19endoscopySARS-CoV-2

Identifiers

PMID35330006
PMCPMC8955929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.